OneDigital Investment Advisors LLC boosted its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 23.8% during the third quarter, HoldingsChannel reports. The firm owned 14,829 shares of the company’s stock after buying an additional 2,847 shares during the period. OneDigital Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $1,539,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of CL. Price T Rowe Associates Inc. MD lifted its holdings in shares of Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after acquiring an additional 8,933,912 shares during the last quarter. Swedbank AB bought a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $286,370,000. Acadian Asset Management LLC raised its holdings in shares of Colgate-Palmolive by 108.4% during the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after buying an additional 2,955,442 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Colgate-Palmolive by 40.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock worth $870,400,000 after buying an additional 2,593,313 shares during the last quarter. Finally, Ossiam boosted its stake in Colgate-Palmolive by 368.4% in the first quarter. Ossiam now owns 1,563,768 shares of the company’s stock worth $140,817,000 after buying an additional 1,229,891 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the stock. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Thursday. JPMorgan Chase & Co. boosted their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Finally, Hsbc Global Res lowered Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $105.11.
Insiders Place Their Bets
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 16.44 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by corporate insiders.
Colgate-Palmolive Stock Up 2.3 %
CL stock opened at $93.56 on Monday. Colgate-Palmolive has a fifty-two week low of $75.17 and a fifty-two week high of $109.30. The company has a market capitalization of $76.44 billion, a price-to-earnings ratio of 26.81, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The business’s 50 day moving average price is $99.31 and its two-hundred day moving average price is $98.54. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s payout ratio is 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Dividend Payout Ratio Calculator
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Most Important Warren Buffett Stock for Investors: His Own
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Want to Profit on the Downtrend? Downtrends, Explained.
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.